(Q35193397)

7 August 2017

1 reference

title

Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy (English)

1 reference

7 August 2017

0 references

1 reference

Douglas Noonan

5

0 references

Ulrich Pfeffer

object named as

Ulrich Pfeffer

2

0 references

Stefano Indraccolo

object named as

S Indraccolo

3

0 references

Adriana Albini

object named as

Adriana Albini

4

0 references

author name string

Raffaella Dell'Eva

1

1 reference

7 August 2017

1 January 2002

1 reference

Endothelium: Journal of Endothelial Cell Research

7 August 2017

1 reference

7 August 2017

9

1 reference

7 August 2017

1

1 reference

7 August 2017

3-10

1 reference

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

7 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Is angiogenesis inhibition the Holy Grail of cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

The hemostatic system as a regulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Transfer of genes to humans: early lessons and obstacles to success

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Isolation of a tumor factor responsible for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Induction of angiogenesis during the transition from hyperplasia to neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Progress in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Gene therapy: adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Nonviral gene therapy: the promise of genes as pharmaceutical products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Systemic gene delivery expands the repertoire of effective antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiostatin binds ATP synthase on the surface of human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Direct gene transfer for treatment of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Antiangiogenic activity of the cleaved conformation of the serpin antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

High rate of mismatch extension during reverse transcription in a single round of retrovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Regulatable promoters for use in gene therapy applications: modification of the 5'-flanking region of the CFTR gene with multiple cAMP response elements to support basal, low-level gene expression that can be upregulated by exogenous agents that rai

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Gene therapy, concepts, current trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

When bad gene transfer is good

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Regulatory considerations for gene-therapy strategies and products

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

Suppression of tumor growth with recombinant murine angiostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320210712

21 January 2018

Identifiers

DOI

10.1080/10623320210712

1 reference

7 August 2017

1 reference

PubMed ID

12901356